×

XIV Fórum de Sepse

Palestrantes Internacionais

  • Argentina

Arnaldo Dubin

CU Medical Director of Sanatorio Otamendi de Buenos Aires y Professor in Universidad Nacional de La Plata.

  • Inglaterra

Andrew Rhodes

Andrew Rhodes trained in Medicine at the St George’s, University of London qualifying in 1990. He underwent specialist training in Anaesthesia and Intensive Care Medicine and became a consultant at St George’s Hospital, London in 1999. He is currently the Chair of the Children's, Women's, Diagnostics, Therapies and Critical Care Division of St George’s Healthcare NHS Trust, a Professor in Anaesthesia and Intensive Care Medicine at the St George’s University of London and the Trust's deputy Medical Director. Andrew has held leadership roles at both a national and an international level. He currently represents the South London Senate to the Adult Critical Care Clinical Reference Group at NHS England. He is a Council member of the Faculty of Intensive Care Medicine (FICM) and a past president of the European Society of Intensive Care Medicine (ESICM). He is the current co-chair of the Surviving Sepsis Campaign.

  • Irlanda

Ignacio Martin-Loeches

Ignacio Martin-Loeches, PhD, FJFICMI is a full time Consultant in Intensive Care Medicine and Senior Clinical Lecturer & Research Director of the Multidisciplinary Intensive Care Research Organization (MICRO) at Trinity College, Dublin. Currently Vice-Chair of Intensive Care Medicine at St James’s University Hospital, Dublin. He has served as executive member for the European Diploma in Intensive Care (EDIC) and as Deputy for the Sepsis and Infection Section at the European Society of Intensive Care Medicine (ESICM). He is the Chair of the Severe Sepsis and Septic Shock Working Group “4SWG” and executive member of the research-working group of the Surviving Sepsis Campaign (SSC). He is the currently member of the Clinical Trials of Health Research Board in Ireland and the President of the Spanish Research Society of Ireland [(under the Embassy of Spain in Ireland and The Spanish Foundation for Science and Technology (FECYT)]. He is principal Investigator of European Regional Development Funds (ERDF) grant and the European Network for ICU-related respiratory infections (ENIRRIs) under the European Respiratory Society (ERS). He has published several manuscripts in high impact factor journal and serves as section Editor at the Intensive Care Medicine (ICM) journal.

  • Estados Unidos

Theodore (Jack) Iwashyna

Jack Iwashyna is an Associate Professor of Internal Medicine, Faculty Associate of the Institute for Social Research Survey Research Center, and co-Director of the National Clinician Scholars at the University of Michigan. Much of his interest in understanding if, when, and how critical illness and critical care bend the long arc of people’s lives. That includes work on long-term outcomes, on survivor peer support, and persistent critical illness. A major focus of his work is mentoring.

  • Estados Unidos

Mitchell Levy

Mitchell M. Levy MD is Chief, Division of Critical Care, Pulmonary, and Sleep Medicine, Department of Medicine, The Warren Alpert Medical School of Brown University, where he is Professor of Medicine. He is also Medical Director of the Medical Intensive Care Unit at Rhode Island Hospital, Providence, Rhode Island. Dr. Levy is a founding member (2002) and a member of the Executive Committee of the Surviving Sepsis Campaign, a global initiative to improve the care of patients with severe sepsis. He is the lead investigator for Phase III of the campaign, the goal of which is to facilitate adoption of evidence-based guidelines for sepsis management into clinical practice and reduce mortality in severe sepsis by 25% by 2009. Dr. Levy is Past-President of the Society of Critical Care Medicine (2009). Dr. Levy’s current research interests include biomarkers in sepsis, end-of-life care in the ICU, and knowledge translation. He has authored over 130 peer-reviewed articles and book chapters. He is the co-director of the Ocean State Clinical Coordinating Center, which manages large, international, multi-center clinical trials in sepsis. Dr. Levy is very active in the field of quality and safety. He continues to serve as the representative to the National Quality Forum for SCCM and also serves on the advisory committees on Quality for the Blue Distinction program of Blue Cross Blue Shield of America. Dr. Levy has worked on several state-wide initiatives on quality, including Rhode Island and New Jersey, and has led a similar initiative for the New York City Health and Hospital Corporation in their quality initiative in catheter-related bloodstream infection and sepsis. He was recently appointed a content expert and voting member of the Hospital Workgroup of the Measure Applications Partnership (MAP) of the National Quality Forum and serves as a technical expert for the project Closing the Quality Gap: Prevention of Healthcare-associated Infections, which is part of the Evidence-Based Practice Center (EPC) program of the Agency for Healthcare Research and Quality (AHRQ).

  • Holanda

Tom Van der Poll

Tom van der Poll is Professor of Medicine in the Academic Medical Center (AMC), University of Amsterdam, the Netherlands. He is Head of the Center of Experimental and Molecular Medicine and Chair of the Division of Infectious Diseases in this institution. Van der Poll is board certified in Internal Medicine and Infectious Diseases. He is a member of the Dutch Health Council, the official advisory board of the Dutch government and parliament. He is the current Chair of the International Sepsis Forum, and council member of the Global Sepsis Alliance. His training included a postdoctoral research fellowship in Cornell University Medical College in New York (1993-1995). Van der Poll is a former Fellow of the Royal Dutch Academy of Arts and Sciences (1995-2000). His research focuses on the innate immune and procoagulant response during sepsis. He has published more than 600 original articles and over 60 book chapters on this topic. His research is embedded in the Center for Infection and Immunity Amsterdam (CINIMA).